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D 4.14 Surveillance After Revascularization
D 4.14.1 Introduction
Despite a high likelihood of immediate success, all lower-extremity revascularization procedures
have a significant rate offailure over time (see also B 4.4, Surgery for Intermittent Claudication,
p S113). It is now well recognized that patency of the treated arterial segment is most effective-
ly preserved through surveillance programs that are capable of identifying flow-limiting lesions
before complete occlusion of the conduit or vessel,l,2,3,4 Revision offailing reversed saphenous
vein bypass grafts, for example, results in excellent long-term graft function, with assisted prima-
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ry patencies of 82% to 92% at 5 years.5,6 Once complete occlusion has occurred, thrombectomy
and revision yields a poorer secondary patency of only 43% to 76%at 5 ycars.7,8,9 Similarly, the
treatment of complete rc-occlusions of angioplasty sites has a lower likelihood of technical suc-
cess, a higher incidence of complications, and yields a less durable result.IO,l l
Clearly, the identification and treatment of flow-limiting lesions within the treated arterial seg -
ment before thrombosis of the segment provides a more durable result . Surveillance programs,
therefore, represent a potentially valuable adjunct to every type of vascular intervention per-
formed for the preservation of lower extremity perfusion. Because not all peripheral interven-
tions are easily evaluated, the methods that provide the most cost-effective surveillance in a
given setting remain controversial.
D 4.14.2 Methods of Surveillance
A number of methods of posttreatment surveillance of patients undergoing lower extremity
revascularization have been practiced over the past several decades. These include clinical exami-
nation, ankle.brachial indices, duplex imaging, and arteriography. Additional study methods
have been used, such as segmental pressures and plethysmography, but little information exists
regarding the utility of these technologies.
Patient history and clinical examination
Most patients (66%) who have undergone femoropopliteal or femorotibial bypass procedures
experience a return of preoperative symptoms immediately on graft occlusion.P Unfortunately,
few of these patients develop slowly progressive symptomatology during the development of
flow-limiting or graft-threatening lesions.lf This is especially true of those patients who do not
participate in a postoperative exercise therapy program and remain sedentary. Therefore,
although patient history is an essential and valuable source of information, alone it is of little
value in detecting the development and evolution of luminal lesions capable of causing graft
thrombosis.
Physical examination also lacks sufficient sensitivity for the detection of failing grafts or angie-
plasty sites.l4 ,IS Isolated stenoses of inflow or outflow vessels or of a graft infrequently alter
physical examination. Similarly, pulse examination of the patient at rest and the appearance of
the foot may not be changed by the presence of a significant isolated steuosis.lv Graft occlusion
occurs in many patients before the onset of symptoms or alteration in the quality and character
of peripheral pulses . Therefore, clinical history and physical examination are inadequate as the
sole components for graft surveillance and the reliable detection of failing femoropopliteal or
femorotibial bypass grafts. Patient history and physical examination remain, however, essential
components of any surveillance program.
Ankle:brachial pressure indices
The use of resting ABPI for the detection of hemodynamically significant arterial occlusive dis-
ease has been uniformly accepted, although they may be subject to measurement variability and
study limitations. Individual recordings ofABPI in a patient may vary by as much as 0 .1 with-
out a fixed reduction in peripheral blood flow. A decrease in index of 0.15 , the parameter most
widely used as representative of a significant reduction in blood flow, requires the development
of a hemodynamically significant stenosis of at least 50%.17 These high-grade stenoses are more
likely to undergo sudden thrombotic occlusion. The inabiJity to identify mild or moderate flow-
reducing lesions prevents the recording of slowly falling ABPI in patients with an evolving graft-
related stenosis.l8,19 Additionally, resting ABPI may be falsely elevated in patients with calcified
distal arteries and may be of limited value in patients who did not normalize their ABPI in the
immediate postoperative period. These factors limit the usefulness of the resting ABPI for the
detection of failing lower extremity revascularizations.
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One group of investigators has documented equivalent graft failure rates in patients with hemo-
dynamically significant drops in resting ABPI (>0.2) and those with stable ABpI,18 Similarly,
another group has shown that a decrease in resting ABPI of 0.2 did not distinguish between
patients who proceeded to graft occlusion and those who did not.l? For these reasons, the rest-
ing ABPI cannot reliably provide the physician with information regarding the development of
stenoses and the probability of a thrombotic episode within angioplasty sites or bypass grafts.
Toe:brachial indices provide no better discrimination.s'' The measurement ofpost-exercise ABPI
may improve the detection of flow-limiting stenoses. A well-recognized method for enhancing
the detection of subcritical stenoses in native vessels, post-exercise ankle-brachial indices have
been shown to be of greater value than resting ABPI for the identification of failing lower
extremity angioplasty.21 A recent application of this form of ABPI assessment showed that a sig-
nificant number of patients with significant graft stenoses experienced a reduction in post-exer-
cise ABPI despite an unchanged resting ABPI.22 Thus, the post-exercise ABPI may be helpful in
the detection of suprainguinal reconstructions or lower extremity angioplasty procedures.
Colorflow duplex scanning
Color flow duplex scanning has been widely used in surveillance programs because of its simpli-
fied ability to identify stenoses in native arteries and vein grafts. Color guidance has reduced the
amount of time required to locate significant lesions within autogenous grafts and, therefore,
has made rapid scanning of the entire graft length in the lower extremity feasible. Scans can be
performed longitudinally and can detect a variety of conditions that may impact on graft func-
tion, including persistent arteriovenous fistulae, compressive hematoma, kinks or other forms of
graft malpositioning, and pseudoaneurysms.
A graft can be evaluated at each anastomosis and throughout its length. Areas of concern can be
reexamined at frequent intervals if clinically indicated to identify the extent and rate of develop-
ment of stenotic lesions. Duplex surveillance of lower extremity vein grafts is more easilyaccom-
plished than prosthetic grafts because of the ability to completely scan the graft and identify
areas of stenosis and altered flow rates. The flow surface contours of a normal vein graft should
be smooth and parallel on longitudinal scan. A recent study has shown that baseline graft peak.
flow velocities vary with the site of distal anastomosis (popliteal vs tibial) and quality of outflow
tract. 23 Vein grafts to the popliteal artery had a mean peak flow velocity of 89.5 cm/s, whereas
those to the tibial vessels had a mean peak flow velocity of 64 cmys,
Although criteria for graft failure vary among laboratories, there are general guidelines for
detection of the failing distal graft. These include an increase in peak systolic velocity to greater
than 150 cmy's, a peak systolic velocity ratio of greater than 2.0 across a stenosis, and a reduc-
tion in peak. systolic velocity to less than 45 cmys, Because luminal diameter is narrowed within
a native artery or autogenous graft, peak systolic velocities within the lesion increase. A peak sys-
tolic velocity of 150 to 170 cm/s correlates with a greater than 50% diameter reduction.P A
peale systolic velocity of 180 cmys or greater suggests a critical diameter reduction of 80% or
more.25As the peak systolic velocity increases, end-diastolic velocity may also begin to rise,
End-diastolic velocities of greater than 50 crnys in conjunction with high peak systolic velocities
indicate a greater than 70% loss of luminal diameter.if A reduction of peak systolic velocity to
less than 45 cmys at the site of the smaller of the anastomoses (proximal in reversed vein grafts,
distal in situ) suggests a proximal flow-limiting lesion but is less specific than either peak systolic
or end-diastolic velocity rneasurements.J?
Because peak velocities within a vein graft may vary from the established baseline, velocity ratios
have been used to detect the presence of significant stenoses. The peak systolic velocity ratio is
calculated by dividing the peak systolic velocity at the site of the stenosis by that obtained in the
normal segment. A ratio greater than 2.0 suggests the presence of a 50% diameter-reducing
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lesion.27,28 An elevated peak. systolic velocity ratio in conjunction with elevated peak velocities
and the identification of an anatomic lesion on duplex image are strongly suggestive of a signifi-
cant, graft-threatening stenosis. The use of duplex imaging for the evaluation of prosthetic
bypass grafts is more limited. Because clear luminal images frequently cannot be obtained within
synthetic grafts, especiallyePTFE, the benefit of duplex imaging is limited to the evaluation of
the anastomoses and the inflow and outflow vessels. The value of performing a truncated scan
such as this remains controversial.
More recently, duplex imaging has been applied to the surveillance of transluminal angioplasty
of the lower extremity. Although the presence of significant amounts of calcium in the arterial
wall may prevent clear visualization of the specific angioplasty site, peak systolic flow velocities
across the site can be determined, and peak systolic velocity ratios can be calculated. These val-
ues are capable of detecting the presence of restenosis of the angioplasty site or the worsening
of occlusive disease in adjacent segments. 10,29
The use of peak systolic velocities and velocity ratios enhance the ability of color flow duplex
imaging to detect mild, moderate, and severe stenoses. This surveillance modality is capable of
detecting stenoses of less than 50%, permitting physicians to follow the evolution of these
lesions and plan appropriate therapy. The greatest limitation to this technique of patient evalua-
tion is its operator dependency. Optimal results with color duplex imaging for surveillance
requires an experienced technologist who can not only identify the presence of a stenotic lesion
by velocity criteria but also provide information about the location and characteristics of the
lesion. It might be that MRA should be advised if patients have heavily calcified vessels, or if
other reasons exist for ABPI being inadequate, or if good quality color duplex scanning either is
not available or cannot be performed adequately because of patient habitus.
Angiography
Angiography is well accepted as the "gold standard" for anatomic diagnostic studies. Biplanar arteri-
ography is associatedwith high positive and negative predictive values for the detection of stenoses
within native arteries and autogenous and prosthetic grafts. Appropriately performed, this diagnostic
test can identify the presence, location, and severity of occlusive lesion within the segment of arterial
tree imaged. Unlike the noninvasivestudies, image clarity does not decrease above the inguinalliga-
ment, and the mobility of newer imaging systems permits a wide variety ofviews capable ofprovid-
ing significantanatomic information. The retrograde measurement of pressure gradients across iliac
lesionscan contribute valuable hemodynamic information about inflow vessels.
The morbidity and mortality of angiography, though quite low, plus patient discomfort and
cost, make this an unacceptable routine method of surveillance. 30,3 I Its role as an adjunctive
diagnostic modality to confirm noninvasive duplex findings, or to provide additional anatomic
detail about a specific stenotic lesion is, however, important.
D 4.14.3 Appropriate Use of Graft Surveillance
Overall, surveillance programs have shown the benefit of duplex imaging for the detection of vein
graft stenoses that, ifuntreated, would result in graft occlusion.P Postoperatively, the develop-
ment of lesions that threaten graft patency of saphenous vein bypasses occur most often within
the body of the graft. In a study of occluded and failing saphenous vein grafts, 63% of the lesions
were located within the graft, and 20% were at the anastomoses.V As an easily repeated diagnos-
tic test with excellent patient compliance, duplex imaging permits frequent assessment of luminal
irregularities and the detection of hemodynamically significant stenoses that, when corrected,
help preserve vein graft function. It has been suggested that surveillance may be restricted to the
first 6 months after operation in those patients who have a normal bypass during that period.34
Treatment of hemodynamically significant lesions in nonocduded but failing saphenous vein
grafts results in primary assisted patency rates greater than 80% at 5 years.1,2,3,4,5,6
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The time of initiation of duplex imaging surveillance programs varies among practicing centers.
Most, however, obtain the first postoperative scan at 1 week or before discharge. The initial scan
may detect a wide variety of graft conditions that might impact on graft survival.35 These
include the identification of persistent, large arteriovenous fistulae that may divert distal flow in
in situ bypasses, compressive hematoma, anastomotic pseudoaneurysms, as well as retained
valves, adherent thrombus, and luminal flaps.
The detection of luminal pathology not discovered in the operating room at the time of graft
placement has been reported to occur in as many as 37% of patients, with 32%of these compro-
mised grafts ultimately requiring revision of the identified lesion.35 Subsequent surveillance stud-
ies have been performed on a wide variety of schedules. Most commonly for patients with auto-
genous lower extremity bypass, graft surveillance studies are performed at 1, 3,6, 12, 18 and 24
months, and then yearly thereafter. The cost-effectiveness of frequent surveillance beyond 2 years
is controversial because of the reduced incidence of graft failure after this period. 3,36 The cost-
effectiveness of Duplex scanning during the first year has also been questioned. 37
Recommendation 97: Surveillance program for vein bypass il'afts
Patients undergoing vein bypass graft placement in the lower extremity for the treat-
ment of claudication or limb-threatening ischemia should be entered into a surveillance
program. This program should consist of:
• interval history (new symptoms)
• vascular examination of the leg with palpation of proximal, graft, and outflow vessel pulses
• periodic measurement of resting and, if possible, post-exercise ankle:brachial indices
• duplex scanning of the entire length of the graft, with calculation of peak systolic
velocities and the velocity ratios across all identified lesions
Surveillance programs should be performed in the immediate postoperative period and
at regular intervals for at least 2 years.
Critical Issue 39: Cost-effectiveness of duplex imaging surveillance for vein grafts
There is a need for documenting the cost-effectiveness of using duplex imaging for vein
graft surveillance at all periods.
Critical Issue 40: Frequency and duration of surveillance in vein and prQsthetic il'afts
There is a need to establish optimal frequency and duration of surveillance testing in
vein and prosthetic grafts.
The indications for treatment of an identified lesion must be individualized for each specific
patient. Numerous variables impact on graft function and limb salvage. Nonetheless, the value
of a surveillance program lies in its ability to identify for the vascular specialist the graft threat-
ened by flow-limiting lesions. The impact of such lesions on long-term graft function has been
.well recognized and defined. 38,39 Because stenotic lesions causing a greater than 50%diameter
reduction are at greater risk for acute thrombosis, the identification of such lesions should lead
the vascular specialist to consider treatment.w Prompt, definitive evaluation of tile entire graft,
inflow, and outflow vessels, with angiography if necessary, and intervention, if indicated, should
be undertaken. Delay in the evaluation and treatment of grafts at risk may result in graft failure
and a poorer prognosis for the patient.t!
Duplex imaging, however, has not been uniformly effective for the detection of failing prosthet-
ic grafts.42,43 Surveillance of prosthetic bypasses with duplex imaging may not detect impending
graft failure secondary to lesions within the graft.44 Technical difficulties associated with scan-
ning of tile graft, especially those prosthetics with external support, frequently yield suboptimal
images. The benefit of surveillance in patient with prosthetic grafts lies in the likelihood that the
graft-threatening lesion usually does not occur within the body of the graft. Of 144 graft-threat-
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ening lesions identified in 91 failing PTFE bypass grafts, only 10 stenoses (8%) were located
within the graft. The remainder were located within the inflow vessel (30%), outflow vessel
(57%), or at an anastomosis (6%).45 Other studies have shown a benefit of duplex image surveil-
lance for prosthetic grafts.46,47 Though the benefit of duplex imaging alone appears to be limit-
ed, a surveillance program for patients who have undergone placement of a synthetic bypass
graft is indicated.
Reconunendation 98: Syrveillance program for prosthetic &rafts
Patients undergoing prosthetic femoropopliteal or femorotibial bypass for claudication
or limb-threatening ischemia should be entered into a graft surveillance program, which
consists of:
• interval history (new symptoms)
• vascular examination of the leg with palpation of proximal, graft, and outflow vessel
pulses
• ankle:brachial indices at rest and, if possible, after exercise testing
Surveillance programs should be performed in the immediate postoperative period and
at regular intervals for at least 2 years.
The benefit of surveillance programs for patients who have been treated with proximal vascular
reconstruction, such as aortoiliac or iliofemoral bypass, or transluminal angioplasty, remains con-
troversial. Some studies have demonstrated a benefit to surveillance with duplex imaging.l0,29,48
Few studies have been rigorously performed to determine the impact of a surveillance program
on the long-term outcome of angioplasty.
A recent study of duplex sonography surveillance initiated within 48 hours of infrainguinal
angioplasty and continued for more than 2 years failed to detect a difference in patency of
angioplasty sites between those patients who had abnormal results of duplex examinations and
those whose examination results were normal.t? Similarly, investigators have shown that resting
ABPI does not identify patients with significant restenosis. Post-exercise ABPI measurement is
more likely to show the presence of hemodynamically significant Iesions.U
Reconunendation 99: Surveillance program for aortoiliac translurninal angioplasty
Patients undergoing aortoiliac vascular reconstruction or transluminal angioplasty for lower
extremity revascularization should be entered into a surveillance program consisting of:
• interval history (new symptoms)
• vascular examination of the leg with palpation of proximal and outflow vessel pulses
• resting and, ifpossible, post-exercise ABPI recording
Surveillance programs should be performed in the inunediate post-PTA period and at
intervals for at least 2 years.
Critical Issue 41: Surveillance program for angioplasty and other endovascular produres
There is a need for confirmation that the surveillance program suggested for vein bypass
grafts is also beneficial after endovascular procedures.
D 4.14.4 Management of a Failing Lower Extremity Revascularization
The identification of a failing lower extremity autogenous bypass by duplex imaging surveillance
frequently provides the physician with sufficient information to plan intervention. This is espe-
cially true of in situ saphenous vein bypass grafts.l- 2, 3,4, 5,6 The presence of hemodynamically
significant stenoses within the graft or the progression of a mild lesion to one of hemodynamic
significance should indicate tile need for intervention. Many techniques have been used success-
fully to treat these lesions, including balloon angioplasty, patch angioplasty, and segmental vein
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resection and interposition vein graft. The interposition of a prosthetic segment into a vein graft
is of dubious value.
The detection of a decreasing resting or post-exercise ABPI in a patient with a prosthetic
intra-inguinal bypass should lead to angiographic assessment of the patient. Because duplex
imaging fails to adequately image the flow surface of prosthetic grafts, intervention requires a
complete and detailed evaluation of the intlow, prosthetic, and outflow vessels. Only then can
appropriate intervention be planned, Patients with stenoses within the native inflow or outflow
arteries may be treated by conventional angioplasty or surgical techniques. Stenoses within the
body of the prosthetic graft are best treated by direct surgical revision. Angioplasty has not been
of demonstrated benefit in the treatment of these lesions.
A decrease in the resting or post-exercise ABPI in patients who were treated by translurninal
angioplasty should be studied by angiography to determine the feasibility of performing a redila-
tion of the lesion. Duplex imaging of lower-extremity angioplasty sites may be of value for the
assessment of lesions in patients who do not clearly warrant intervention. Patients who have had
rapid restenosis of an angioplasry site or who have required multiple repeat angioplasties should
be considered for surgical intervention. The point at which a graft stenosis becomes critical, that
is, the point beyond which thrombosis is very likely to occur, has not been determined. There
appears to be a transition from a low to high risk between a 50% and 75% stenosis. 25,50 In addi-
tion, whether velocity criteria from Duplex scanning or anatomic criteria from angiography best
identify the critical risk point is debated. More research is needed to settle this important issue.
Critical Issue 42: Intervention during surveillance program
There is a need for further information to identify what degree of lesion( s) restenosis,
as detected by surveillance studies, must be corrected.
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